ClinicalTrials.Veeva

Menu

Expressive Writing for the Management of Stress in Cancer Survivors

M.D. Anderson Cancer Center logo

M.D. Anderson Cancer Center

Status

Enrolling

Conditions

Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm

Treatments

Behavioral: Behavioral Intervention
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04776941
NCI-2021-00218 (Registry Identifier)
2020-0538 (Other Identifier)

Details and patient eligibility

About

This clinical trial evaluates the effect of expressive writing for the management of stress in cancer survivors. Cancer diagnosis and treatment are associated with increased stress in cancer survivors related to concerns about family, career, relationships, finances, side effects of treatment, and death. This stress can be further exacerbated by social upheavals such as the COVID-19 pandemic. For safety reasons, many patients are isolated with restricted access to in-person health care and reduced social interaction with family and friends. Together with the economic uncertainties that come with this pandemic, these factors are likely to increase cancer survivors' stress levels. Expressive writing may provide a medium through which cancer survivors confront stressors and find meaning in their experience. The goal of this trial is to learn more about the experiences of cancer survivors during stressful times.

Full description

PRIMARY OBJECTIVES:

I. To evaluate the feasibility of the virtual study for cancer survivors. II. To preliminarily assess the impact of the intervention for cancer survivors.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I (INTERVENTION): Patients complete questionnaires over 30 minutes about their mood, health, and income at baseline, and 1, 3, and 6 months. Patients also read brief positive messages and write essays about their experiences over 30 minutes (non-stop) once weekly (QW) for 3 weeks.

ARM II (CONTROL): Patients complete questionnaires over 30 minutes about their mood, health, and income at baseline, and 1, 3, and 6 months. Patients also read brief neutral messages and write essays about neutral topics over 30 minutes (non-stop) QW for 3 weeks.

Enrollment

414 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • At least 18 years old
  • Have a diagnosis of cancer within the past 3 years
  • Are able to speak and read in English
  • Have access to a computer or smart phone with internet connection
  • All disease sites and all cancer stages are eligible for enrollment

Exclusion criteria

  • Inability to provide informed consent
  • Non-English speakers will be excluded because this is a feasibility study that will enroll only a limited number of participants

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

414 participants in 2 patient groups

Arm I (questionnaires, messages, writing)
Experimental group
Description:
Patients complete questionnaires over 30 minutes about their mood, health, and income at baseline, and 1, 3, and 6 months. Patients also read brief positive messages and write essays about their experiences over 30 minutes (non-stop) QW for 3 weeks.
Treatment:
Other: Questionnaire Administration
Other: Quality-of-Life Assessment
Behavioral: Behavioral Intervention
Behavioral: Behavioral Intervention
Behavioral: Behavioral Intervention
Behavioral: Behavioral Intervention
Arm II (questionnaires, messages, writing)
Active Comparator group
Description:
Patients complete questionnaires over 30 minutes about their mood, health, and income at baseline, and 1, 3, and 6 months. Patients also read brief neutral messages and write essays about neutral topics over 30 minutes (non-stop) QW for 3 weeks.
Treatment:
Other: Questionnaire Administration
Other: Quality-of-Life Assessment
Behavioral: Behavioral Intervention
Behavioral: Behavioral Intervention
Behavioral: Behavioral Intervention
Behavioral: Behavioral Intervention

Trial contacts and locations

1

Loading...

Central trial contact

Qian LU, MD,PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems